Home/Filings/4/0001144204-12-026008
4//SEC Filing

Mak Tak W. 4

Accession 0001144204-12-026008

CIK 0000895051other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 8:51 PM ET

Size

7.7 KB

Accession

0001144204-12-026008

Insider Transaction Report

Form 4
Period: 2012-05-01
Mak Tak W.
Director
Transactions
  • Purchase

    Common Stock

    2012-05-01+352,857365,376 total
  • Award

    Warrants (Right to Buy)

    2012-01-20+69,56569,565 total
    Exercise: $1.40From: 2012-07-29Exp: 2017-07-29Common Stock (69,565 underlying)
Footnotes (2)
  • [F1]Reflects the conversion price of a certain Subordinated Mandatorily Convertible Note ("Convertible Note") acquired in connection with the Company's strategic financing entered into on January 20, 2012 ("Strategic Financing"). The Convertible Note automatically converts into shares of common stock, at the conversion price of $1.15, upon stockholders approval of the Strategic Financing. The conversion price reflects the 10-day average closing sale price of the Company's Common Stock ending on January 20, 2012. The stockholders approved the Strategic Financing at the Company's Annual Stockholders Meeting held on April 30, 2012 ("2012 Annual Meeting").
  • [F2]Warrants were acquired in connection with the Strategic Financing and become exercisable at any time on or after 90 days following the 2012 Annual Meeting.

Issuer

ENTREMED INC

CIK 0000895051

Entity typeother

Related Parties

1
  • filerCIK 0001542072

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 8:51 PM ET
Size
7.7 KB